DALLAS, Feb. 14, 2012 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring Complete Genomics Inc. (Nasdaq:GNOM). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
MicroStockProfit.com is the premier destination for investment information, making your trading decisions easier than ever. Get the rundown on how GNOM stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for GNOM at: http://www.microstockprofit.com/lp/GNOM
This newsletter has been helping traders make great investment decisions on GNOM; click here for a 15% discount offer.
In the report, the analyst notes:
"Shares of GNOM spiked as much as 65% to reach an intraday high of $5.42 Monday, boosted by news the Company has entered into a deal with the Mayo Clinic's Center for Individualized Medicine to provide large-scale genomic sequencing services."
"GNOM reported revenue of $4.2 million for the third quarter ended September 30, 2011, compared to $4.2 million in the third quarter of 2010. The Company recognized revenue for over 700 genomes compared to over 300 genomes recognized in the comparable quarter of the prior year."
To read the entire report visit: www.microstockprofit.com/lp/GNOM
See what investors are saying about GNOM at http://www.stockhideout.com
Get breaking news on GNOM at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.